The endovascular management of intracranial vascular disease including the MERCI device

Current Treatment Options in Cardiovascular Medicine

Volumn 9, Issue 2, 2007, Pages 99-108

  Gandhi, Chirag D ^a   Johnson, David M ^b   Patel, Aman B ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; ANTITHROMBOCYTIC AGENT; EPTIFIBATIDE; FIBRINOLYTIC AGENT; HEPARIN; NITINOL; PLACEBO; RETEPLASE; SARUPLASE; STREPTOKINASE; TIROFIBAN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ACUTE DISEASE; ANGIOPLASTY; ANTICOAGULATION; BLOOD CLOT LYSIS; BRAIN ANGIOGRAPHY; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CORONARY STENT; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DRUG TREATMENT FAILURE; EARLY INTERVENTION; EMBOLECTOMY; HUMAN; MIDDLE CEREBRAL ARTERY; MONOTHERAPY; MORTALITY; OCCLUSIVE CEREBROVASCULAR DISEASE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RESTENOSIS; REVIEW; RISK BENEFIT ANALYSIS; STENT; THROMBECTOMY;

EID: 34249667073     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-007-0003-8     Document Type: Review

References (39)

1. American Heart Association: Heart and Stroke Facts Statistics: 1999 Statistical Supplement. Dallas: American Heart Association; 1999.
2. Chambers BR, Norris JW, Shurvell BI, Hachinski VC: Prognosis of acute stroke. Neurology 1987, 37: 221-225.
3. Saito I, Segawa H, Shiokawa Y, et al.: Middle cerebral artery occlusion: correlation of computed tomography and angiography with clinical outcome. Stroke 1987, 18: 863-868.
4. Sacco RL, Kargman DE, Gu Q, Zamanillo MC: Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995, 26: 14-20.
5. Schellinger PD, Fiebach JB, Mohr A, et al.: Thrombolytic therapy for ischemic stroke - a review. Part I - intravenous thrombolysis. Crit Care Med 2001, 29: 1812-1818.
6. Higashida RT, Furlan AJ, Roberts H, et al.: Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003, 34: e109-e137.
7. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group [no authors listed]. N Engl J Med 1995, 333: 1581-1587.
8. Labiche LA, Al-Senani F, Wojner AW, et al.: Is the benefit of early recanalization sustained at 3 months? A prospective cohort study. Stroke 2003, 34: 695-698.
9. Haley EC Jr, Lewandowski C, Tilley BC: Myths regarding the NINDS rt-PA Stroke Trial: setting the record straight. Ann Etnerg Med 1997, 30: 676-682.
10. Ielberg RA, Okon NJ, El-Mitwalli A, et al.: Early dramatic recovery during intravenous tissue plasminogen activator infusion: clinical pattern and outcome in acute middle cerebral artery stroke. Stroke 2002, 33: 1301-1307.
11. Selco SL, Liebeskind DS: Hyperacute imaging of ischemic stroke: role in therapeutic management. Curr Cardiol Rep 2005, 7: 10-15.
12. Kim DJ, Kim DI, Kim SH, et al.: Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy. Neuroradiology 2005, 47: 616-621.
13. Barber PA, Zhang J, Demchuk AM, et al.: Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 2001, 56: 1015-1020.
14. Furlan A, Higashida R, Wechsler L, et al.: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999, 282: 2003-2011.
15. Pessin M, Del Zeppo G, Furlan A: Thrombolytic treatment in acute stroke. In Cerebrovascular Diseases: Nineteenth Princeton Review Stroke Conference. Edited by Moskowitz M, LR Calplan LR. Boston: Butterworth-Heinemann; 1995: 409-418.
16. von Kummer R, Holle R, Rosin L, et al.: Does arterial recanalization improve outcome in carotid territory stroke? Stroke 1995, 26: 581-587.
17. Lewandowski CA, Frankel M, Tomsick TA, et al.: Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999, 30: 2598-2605.
18. Keris V, Rudnicka S, Vorona V, et al.: Combined intra-arterial/ intravenous thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2001, 22: 352-358.
19. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study [no authors listed]. Stroke 2004, 35: 904-911.
20. IMS Study Investigators: Hemorrhage in the Interventional Management of Stroke study. Stroke 2006, 37: 847-851.
21. Lee DH, Jo KD, Kim HG, et al.: Local intra-arterial urokinase thrombolysis of acute ischemic stroke with or without intravenous abciximab: a pilot study. J Vasc Interv Radiol 2002, 13: 769-774.
22. Rubiera M, Alvarez-Sabin J, Ribo M, et al.: Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke. Stroke 2005, 36: 1452-1456.
23. Alexander ML Duckwiler GR, Gobin YP, Vinuela F: Management of intraprocedural arterial thrombus in cerebral aneurysm embolization with abciximab: technical case report. Neurosurgery 2002, 50: 899-901; discussion 901-902.
24. Velat GJ, Burry MV, Eskioglu E, et al.: The use of abciximab in the treatment of acute cerebral thrombo-embolic events during neuroendovascular procedures. Surg Neurol 2006, 65: 352-358; discussion 358-359.
25. Qureshi AI, Saad M, Zaidat OO, et al.: Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke 2002, 33: 1916-1919.
26. Abciximab in acute ischemic stroke: a randomized, double-blind, placebo-controlled, dose-escalation study. The Abciximab in Ischemic Stroke Investigators [no authors listed]. Stroke 2000, 31: 601-609.
27. Kapadia SR, Bajzer CL Ziada KM, et al.: Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapy. Stroke 2001, 32: 2328-2332.
28. Smith WS, Sung G, Starkman S, et al.: Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005, 36: 1432-1438.
29. Furlan AI, Fisher M: Devices, drugs, and the Food and Drug Administration: increasing implications for ischemic stroke. Stroke 2005, 36: 398-399.
30. Becker KJ, Brott TG: Approval of the MERCI clot retriever: a critical view. Stroke 2005, 36: 400-403.
31. Lutsep HL: Thrombolytic and newer mechanical device treatment for acute ischemic stroke. Expert Rev Neurother 2006, 6: 1099-1105.
32. Katz JM, Gobin Y: Merci Retriever in acute stroke treatment. Expert Rev Med Devices 2006, 3: 273-280.
33. Nakano S, Iseda T, Yoneyama T, et al.: Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion: an alternative option to intra-arterial thrombolysis. Stroke 2002, 33: 2872-2876.
34. Yoneyama T, Nakano S, Kawano H, et al.: Combined direct percutaneous transluminal angioplasty and low-dose native tissue plasminogen activator therapy for acute embolic middle cerebral artery trunk occlusion. AJNR Am J Neuroradiol 2002, 23: 277-281.
35. Ringer AJ, Qureshi AI, Fessler RD, et al.: Angioplasty of intracranial occlusion resistant to thrombolysis in acute ischemic stroke. Neurosurgery 2001, 48: 1282-1288; discussion 1288-1290.
36. Lum C, Stys PK, Hogan MJ, et al.: Acute anterior circulation stroke: recanalization using clot angioplasty. Can J Neurol Sci 2006, 33: 217-222.
37. Grines CL, Cox DA, Stone GW, et al.: Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1999, 341: 1949-1956.
38. Levy EI, Ecker RD, Horowitz MB, et al.: Stent-assisted intracranial recanalization for acute stroke: early results. Neurosurgery 2006, 58: 458-463; discussion 458-463.
39. Henkes H, Miloslavski E, Lowens S, et al.: Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (Wingspan). Neuroradiology 2005, 47: 222-228.